149 related articles for article (PubMed ID: 33850546)
1. MicroRNA-361-5p induces hepatocellular carcinoma cell apoptosis and enhances drug sensitivity by targeting MAP3K9.
Ren Q; Xiao X; Leng X; Zhang Q; Zhou X; Ren Z; Xiao H
Exp Ther Med; 2021 Jun; 21(6):574. PubMed ID: 33850546
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-125a-5p targets LIM kinase 1 to inhibit cisplatin resistance of cervical cancer cells.
Xu Y; Zheng Y; Duan Y; Ma L; Nan P
Oncol Lett; 2021 May; 21(5):392. PubMed ID: 33777215
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-362-5p enhances the cisplatin sensitivity of gastric cancer cells by targeting suppressor of zeste 12 protein.
Wei X; Gao M; Ahmed Y; Gao M; Liu W; Zhang Y; Xie X; Zhao Q; Wang H; Gu K
Oncol Lett; 2019 Aug; 18(2):1607-1616. PubMed ID: 31423228
[TBL] [Abstract][Full Text] [Related]
4. miR-186-5p targeting SIX1 inhibits cisplatin resistance in non-small-cell lung cancer cells (NSCLCs).
Liu X; Zhou X; Chen Y; Huang Y; He J; Luo H
Neoplasma; 2020 Jan; 67(1):147-157. PubMed ID: 31686523
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA CASC2 enhances cisplatin sensitivity in oral squamous cell cancer cells by the miR-31-5p/KANK1 axis.
Wang J; Jia J; Zhou L
Neoplasma; 2020 Nov; 67(6):1279-1292. PubMed ID: 32787433
[TBL] [Abstract][Full Text] [Related]
6. Effect of miR-26b-5p on cis-diamine dichloroplatinum-induced ovarian granulosa cell injury by targeting MAP3K9.
Liu S; Li L; Li M; Zhang J
In Vitro Cell Dev Biol Anim; 2020 Mar; 56(3):213-221. PubMed ID: 32185607
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner.
Wang B; Zhang Y; Ye M; Wu J; Ma L; Chen H
Curr Drug Metab; 2019; 20(10):804-814. PubMed ID: 31424364
[TBL] [Abstract][Full Text] [Related]
8. miR-21-5p Suppressed the Sensitivity of Hepatocellular Carcinoma Cells to Cisplatin by Targeting FASLG.
Chen S; Yang C; Sun C; Sun Y; Yang Z; Cheng S; Zhuge B
DNA Cell Biol; 2019 Aug; 38(8):865-873. PubMed ID: 31225740
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1.
Huang XP; Hou J; Shen XY; Huang CY; Zhang XH; Xie YA; Luo XL
FEBS J; 2015 Feb; 282(3):579-94. PubMed ID: 25475121
[TBL] [Abstract][Full Text] [Related]
10. MiR-219a-5p enhances cisplatin sensitivity of human non-small cell lung cancer by targeting FGF9.
Rao C; Miao X; Zhao G; Zhang C; Shen H; Dong C; Yang M
Biomed Pharmacother; 2019 Jun; 114():108662. PubMed ID: 30999114
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of long non-coding RNA HOTAIR reverses cisplatin resistance of ovarian cancer cells through inhibiting miR-138-5p-regulated EZH2 and SIRT1.
Zhang Y; Ai H; Fan X; Chen S; Wang Y; Liu L
Biol Res; 2020 Apr; 53(1):18. PubMed ID: 32349783
[TBL] [Abstract][Full Text] [Related]
12. Elevation of miR-125b-5p is related to improved prognosis in laryngeal squamous cell carcinoma and inhibits the malignancy and glycometabolic disorder by targeting MAP3K9.
Chen F; Lao Z; Zhang HY; Wang J; Wang SZ
Neoplasma; 2022 May; 69(3):550-559. PubMed ID: 35188403
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of miR-3934-5p enhances A549 cell sensitivity to cisplatin by targeting TP53INP1.
Ren A; Wen Z; Zheng L
Exp Ther Med; 2019 Sep; 18(3):1653-1660. PubMed ID: 31410122
[TBL] [Abstract][Full Text] [Related]
14. miR-425-5p suppresses tumorigenesis and DDP resistance in human-prostate cancer by targeting GSK3β and inactivating the Wnt/β-catenin signaling pathway.
Liu S; Wang Q; Liu Y; Xia ZY
J Biosci; 2019 Sep; 44(4):. PubMed ID: 31502580
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-206 facilitates gastric cancer cell apoptosis and suppresses cisplatin resistance by targeting MAPK2 signaling pathway.
Chen Z; Gao YJ; Hou RZ; Ding DY; Song DF; Wang DY; Feng Y
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):171-180. PubMed ID: 30657558
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA LINC00173 enhances cisplatin resistance in hepatocellular carcinoma via the microRNA-641/RAB14 axis.
Zhao G; Zhang A; Sun S; Ding Y
Oncol Lett; 2021 May; 21(5):371. PubMed ID: 33777195
[TBL] [Abstract][Full Text] [Related]
17. MiR-192-5p reverses cisplatin resistance by targeting ERCC3 and ERCC4 in SGC7901/DDP cells.
Xie X; Huang N; Zhang Y; Wei X; Gao M; Li M; Ning J; Liu W; Zhao Q; Wang H; Gu K
J Cancer; 2019; 10(4):1039-1051. PubMed ID: 30854110
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-6809-5p mediates luteolin-induced anticancer effects against hepatoma by targeting flotillin 1.
Yang PW; Lu ZY; Pan Q; Chen TT; Feng XJ; Wang SM; Pan YC; Zhu MH; Zhang SH
Phytomedicine; 2019 Apr; 57():18-29. PubMed ID: 30668319
[TBL] [Abstract][Full Text] [Related]
19. MiR-34a-5p/PD-L1 axis regulates cisplatin chemoresistance of ovarian cancer cells.
Zuo Y; Zheng W; Liu J; Tang Q; Wang SS; Yang XS
Neoplasma; 2020 Jan; 67(1):93-101. PubMed ID: 31777260
[TBL] [Abstract][Full Text] [Related]
20. Reversal of cisplatin resistance by microRNA-139-5p-independent RNF2 downregulation and MAPK inhibition in ovarian cancer.
Chen Y; Cao XY; Li YN; Qiu YY; Li YN; Li W; Wang H
Am J Physiol Cell Physiol; 2018 Aug; 315(2):C225-C235. PubMed ID: 29719173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
